Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal β-lactamase

APMIS

Volumn 108, Issue 9, 2000, Pages 589-600

  Bagge, Niels ^a,b   Ciofu, Oana ^a   Skovgaard, Lene T ^b   Høiby, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biofilm; Ceftazidime; Chromosomal lactamase; Chronic lung infection; Pseudomonas aeruginosa; Resistance

Indexed keywords

BETA LACTAMASE; CEFTAZIDIME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM ISOLATION; BIOFILM; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; STRAIN DIFFERENCE;

PSEUDOMONAS AERUGINOSA;

EID: 0033731952     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2000.d01-102.x     Document Type: Article

References (35)

1. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis due to in vivo selection of stable derepressed beta-lactamase producing strains
2. Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis
3. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of anti-pseudomonal treatment at the Danish CF Center
4. Antimicrobial chemotherapy in cystic fibrosis patients
5. Cystic fibrosis, basic and clinical research
6. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients
7. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods
8. High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment
9. Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime and tobramycin in chronic Pseudomonas aeruginosa infection in cystic fibrosis
10. Microbiology of lung infections in cystic fibrosis patients
11. Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres
12. Chronic P. aeruginosa lung infection in normal and athymic rats
13. Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations
14. Robbins device in biofilm research
15. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate
16. Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients
17. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
18. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients
19. Terminal truncations in AmpC beta-lactamase from a clinical isolate of Pseudomonas aeruginosa
20. Characterization of beta-lactamases
21. Characterization of beta-lactamases in situ on poly-acrylamide gels
22. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre
23. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis
24. Induction of beta-lactamase in Enterobacter cloacae
25. Antibodies against Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to beta-lactams
26. Development of resistance in Pseudomonas aeruginosa to broad-spectrum cephalosporins via step-wise mutations
27. Biofilms, the customized microniche
28. Establishment of aging biofilms: Possible mechanism of bacterial resistance to antimicrobial therapy
29. Bacterial biofilms in nature and disease
30. Prevention and control of bacterial infections associated with medical devices
31. Beta-lactamase-mediated resistance and opportunities for its control
32. Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different beta-lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic region
33. Forty years of beta-lactam research